Compare $REVB vs $VCNX | Chartloom

Compare

$REVB vs $VCNX

Revelation Biosciences Inc · Vaccinex Inc

REVB

Revelation Biosciences Inc

VCNX

Vaccinex Inc

Compare $REVB vs $VCNX

Comparing Revelation Biosciences Inc and Vaccinex Inc

REVBRevelation Biosciences Inc

VCNXVaccinex Inc

REVBRevelation Biosciences Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-76.6%

52W performance

-87.1%

FCF yield

-317.7%

VCNXVaccinex Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

5.4%

YTD performance

0.9%

52W performance

29.8%

FCF yield

-530.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

REVB

VCNX

Detailed metrics comparison

REVB

Revelation Biosciences Inc

VCNX

Vaccinex Inc

Market Cap

REVB$3M

VCNX$3M

Enterprise Value

REVB$-9M

VCNX$2M

Price

REVB$0.76

VCNX$1.14

P/E Ratio

REVBN/A

VCNXN/A

P/S Ratio

REVB0.00x

VCNX5.08x

EV/Sales

REVB0.00x

VCNX3.28x

EV/EBITDA

REVB0.00x

VCNX0.00x

P/B Ratio

REVB0.30x

VCNX1.15x

P/FCF Ratio

REVBN/A

VCNXN/A

EV/FCF

REVB0.90x

VCNX-0.12x

PEG Ratio

REVBN/A

VCNXN/A

Forward P/E (NTM)

REVBN/A

VCNXN/A

Forward P/S (NTM)

REVBN/A

VCNXN/A

Revenue (TTM)

REVB$0

VCNX$601K

Revenue Growth (YoY)

REVBN/A

VCNX5.4%

Forward Rev Growth

REVB115.3%

VCNX0.0%

Gross Margin (TTM)

REVB0.0%

VCNX99.7%

Operating Margin (TTM)

REVB0.0%

VCNX0.0%

EBITDA Margin (TTM)

REVB0.0%

VCNX-3101.7%

Net Margin (TTM)

REVB0.0%

VCNX-3100.5%

FCF Margin (TTM)

REVBN/A

VCNX-2696.8%

Net Income (TTM)

REVB$-19M

VCNX$-19M

FCF (TTM)

REVB$-9M

VCNX$-16M

EPS (TTM)

REVB-$5.01

VCNX-$5.78

ROE (TTM)

REVB-10020.0%

VCNX-14678.0%

ROA (TTM)

REVB-8273.0%

VCNX-43375.0%

ROIC (TTM)

REVB-10020.0%

VCNX-14238.0%

Cash

REVB$11M

VCNX$1M

Debt

REVB$0

VCNX$25K

Net Cash/Debt

REVB$11M

VCNX$1M

Current Ratio (TTM)

REVB6.21x

VCNX0.50x

Quick Ratio (TTM)

REVB6.11x

VCNX0.38x

Debt/Equity (TTM)

REVB0.00x

VCNX0.03x

Debt/Assets (TTM)

REVB0.0%

VCNX0.0%

Interest Coverage (TTM)

REVBN/A

VCNXN/A

Net Debt/EBITDA (TTM)

REVB0.00x

VCNX0.00x

Beta

REVB-0.14

VCNX0.73

52W Performance

REVB-87.1%

VCNX29.8%

YTD Performance

REVB-76.6%

VCNX0.9%

% from 52W High

REVB-87.8%

VCNX-24.0%

% from 52W Low

REVB1.3%

VCNX267.7%

Asset Turnover (TTM)

REVB0.00x

VCNX0.14x

FCF Yield (TTM)

REVB-317.7%

VCNX-530.5%

Earnings Yield (TTM)

REVB-646.3%

VCNX-609.9%

Dividend Yield (TTM)

REVBN/A

VCNXN/A

Rule of 40

REVB0.0

VCNX-2,691.4

EV/GP/RG

REVBN/A

VCNXN/A

Ticker research

View REVB research View VCNX research

Metric	REVB Revelation Biosciences Inc	VCNX Vaccinex Inc
Market & Valuation
Market Cap	$3M	$3M
Enterprise Value	$-9M	$2M
Price	$0.76	$1.14
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	5.08x
EV/Sales	0.00x	3.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.30x	1.15x
P/FCF Ratio	N/A	N/A
EV/FCF	0.90x	-0.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$601K
Revenue Growth (YoY)	N/A	5.4%
Forward Rev Growth	115.3%	0.0%
Profitability
Gross Margin (TTM)	0.0%	99.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-3101.7%
Net Margin (TTM)	0.0%	-3100.5%
FCF Margin (TTM)	N/A	-2696.8%
Net Income (TTM)	$-19M	$-19M
FCF (TTM)	$-9M	$-16M
EPS (TTM)	-$5.01	-$5.78
ROE (TTM)	-10020.0%	-14678.0%
ROA (TTM)	-8273.0%	-43375.0%
ROIC (TTM)	-10020.0%	-14238.0%
Financial Health
Cash	$11M	$1M
Debt	$0	$25K
Net Cash/Debt	$11M	$1M
Current Ratio (TTM)	6.21x	0.50x
Quick Ratio (TTM)	6.11x	0.38x
Debt/Equity (TTM)	0.00x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.14	0.73
52W Performance	-87.1%	29.8%
YTD Performance	-76.6%	0.9%
% from 52W High	-87.8%	-24.0%
% from 52W Low	1.3%	267.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.14x
FCF Yield (TTM)	-317.7%	-530.5%
Earnings Yield (TTM)	-646.3%	-609.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-2,691.4
EV/GP/RG	N/A	N/A
Ticker research	View REVB research	View VCNX research

Valuation

P/S Ratio

REVB

0.00x

VCNX

5.08x

EV/FCF

VCNX

-0.12x

REVB

0.90x

Growth & revenue

Revenue Growth TTM

VCNX

5.4%

Forward Revenue Growth

REVB

115.3%

VCNX

0.0%

Profitability & performance

Gross Margin

VCNX

99.7%

REVB

0.0%

ROE

REVB

-10020.0%

VCNX

-14678.0%

FCF Yield %

REVB

-317.7%

VCNX

-530.5%

52-Week Performance

VCNX

29.8%

REVB

-87.1%

Detailed metrics comparison

REVB

Revelation Biosciences Inc

VCNX

Vaccinex Inc

Market Cap

REVB$3M

VCNX$3M

Enterprise Value

REVB$-9M

VCNX$2M

Price

REVB$0.76

VCNX$1.14

P/E Ratio

REVBN/A

VCNXN/A

P/S Ratio

REVB0.00x

VCNX5.08x

EV/Sales

REVB0.00x

VCNX3.28x

EV/EBITDA

REVB0.00x

VCNX0.00x

P/B Ratio

REVB0.30x

VCNX1.15x

P/FCF Ratio

REVBN/A

VCNXN/A

EV/FCF

REVB0.90x

VCNX-0.12x

PEG Ratio

REVBN/A

VCNXN/A

Forward P/E (NTM)

REVBN/A

VCNXN/A

Forward P/S (NTM)

REVBN/A

VCNXN/A

Revenue (TTM)

REVB$0

VCNX$601K

Revenue Growth (YoY)

REVBN/A

VCNX5.4%

Forward Rev Growth

REVB115.3%

VCNX0.0%

Gross Margin (TTM)

REVB0.0%

VCNX99.7%

Operating Margin (TTM)

REVB0.0%

VCNX0.0%

EBITDA Margin (TTM)

REVB0.0%

VCNX-3101.7%

Net Margin (TTM)

REVB0.0%

VCNX-3100.5%

FCF Margin (TTM)

REVBN/A

VCNX-2696.8%

Net Income (TTM)

REVB$-19M

VCNX$-19M

FCF (TTM)

REVB$-9M

VCNX$-16M

EPS (TTM)

REVB-$5.01

VCNX-$5.78

ROE (TTM)

REVB-10020.0%

VCNX-14678.0%

ROA (TTM)

REVB-8273.0%

VCNX-43375.0%

ROIC (TTM)

REVB-10020.0%

VCNX-14238.0%

Cash

REVB$11M

VCNX$1M

Debt

REVB$0

VCNX$25K

Net Cash/Debt

REVB$11M

VCNX$1M

Current Ratio (TTM)

REVB6.21x

VCNX0.50x

Quick Ratio (TTM)

REVB6.11x

VCNX0.38x

Debt/Equity (TTM)

REVB0.00x

VCNX0.03x

Debt/Assets (TTM)

REVB0.0%

VCNX0.0%

Interest Coverage (TTM)

REVBN/A

VCNXN/A

Net Debt/EBITDA (TTM)

REVB0.00x

VCNX0.00x

Beta

REVB-0.14

VCNX0.73

52W Performance

REVB-87.1%

VCNX29.8%

YTD Performance

REVB-76.6%

VCNX0.9%

% from 52W High

REVB-87.8%

VCNX-24.0%

% from 52W Low

REVB1.3%

VCNX267.7%

Asset Turnover (TTM)

REVB0.00x

VCNX0.14x

FCF Yield (TTM)

REVB-317.7%

VCNX-530.5%

Earnings Yield (TTM)

REVB-646.3%

VCNX-609.9%

Dividend Yield (TTM)

REVBN/A

VCNXN/A

Rule of 40

REVB0.0

VCNX-2,691.4

EV/GP/RG

REVBN/A

VCNXN/A

Ticker research

View REVB research View VCNX research

Metric	REVB Revelation Biosciences Inc	VCNX Vaccinex Inc
Market & Valuation
Market Cap	$3M	$3M
Enterprise Value	$-9M	$2M
Price	$0.76	$1.14
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	5.08x
EV/Sales	0.00x	3.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.30x	1.15x
P/FCF Ratio	N/A	N/A
EV/FCF	0.90x	-0.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$601K
Revenue Growth (YoY)	N/A	5.4%
Forward Rev Growth	115.3%	0.0%
Profitability
Gross Margin (TTM)	0.0%	99.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-3101.7%
Net Margin (TTM)	0.0%	-3100.5%
FCF Margin (TTM)	N/A	-2696.8%
Net Income (TTM)	$-19M	$-19M
FCF (TTM)	$-9M	$-16M
EPS (TTM)	-$5.01	-$5.78
ROE (TTM)	-10020.0%	-14678.0%
ROA (TTM)	-8273.0%	-43375.0%
ROIC (TTM)	-10020.0%	-14238.0%
Financial Health
Cash	$11M	$1M
Debt	$0	$25K
Net Cash/Debt	$11M	$1M
Current Ratio (TTM)	6.21x	0.50x
Quick Ratio (TTM)	6.11x	0.38x
Debt/Equity (TTM)	0.00x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.14	0.73
52W Performance	-87.1%	29.8%
YTD Performance	-76.6%	0.9%
% from 52W High	-87.8%	-24.0%
% from 52W Low	1.3%	267.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.14x
FCF Yield (TTM)	-317.7%	-530.5%
Earnings Yield (TTM)	-646.3%	-609.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-2,691.4
EV/GP/RG	N/A	N/A
Ticker research	View REVB research	View VCNX research